Internal link ProQR Therapeutics and Yarrow Biotechnology, an RTW Investments, LP Incubated Company, Announce Exclusive Worldwide License and Discovery Collaboration for Undisclosed Target Maio 04, 2021 at 11:00 AM UTC
Internal link ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Abril 23, 2021 at 11:00 AM UTC
Internal link ProQR Announces Participation in Upcoming Kempen Life Sciences Conference Abril 22, 2021 at 11:00 AM UTC
Internal link ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10 Abril 13, 2021 at 08:15 PM UTC
Internal link ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares Abril 05, 2021 at 08:15 PM UTC
Internal link ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 Abril 02, 2021 at 08:15 PM UTC
Internal link ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Março 31, 2021 at 02:25 AM UTC
Internal link ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares Março 30, 2021 at 08:05 PM UTC
Internal link ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials Março 24, 2021 at 11:00 AM UTC
Internal link ProQR to Present Results from Phase 1/2 Trial of QR-421a for Usher Syndrome Março 17, 2021 at 11:00 AM UTC
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference Março 02, 2021 at 09:30 PM UTC
Internal link ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results Fevereiro 25, 2021 at 12:00 PM UTC
Internal link ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome Fevereiro 16, 2021 at 09:30 PM UTC
Internal link ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10 Janeiro 07, 2021 at 12:00 PM UTC
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference Dezembro 18, 2020 at 12:00 PM UTC
Internal link ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference Novembro 18, 2020 at 12:00 PM UTC
Internal link ProQR Announces Third Quarter 2020 Operating and Financial Results Novembro 16, 2020 at 12:00 PM UTC
Internal link ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO) Novembro 02, 2020 at 12:00 PM UTC
Internal link ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer Outubro 05, 2020 at 11:00 AM UTC
Internal link ProQR Announces Virtual Presentations at Scientific Conferences Setembro 24, 2020 at 08:10 PM UTC
Internal link ProQR to Participate in Upcoming Investor Conferences Setembro 03, 2020 at 11:00 AM UTC
Internal link ProQR Announces Second Quarter 2020 Operating and Financial Results Agosto 06, 2020 at 08:30 PM UTC
Internal link ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy Julho 21, 2020 at 11:00 AM UTC
Internal link ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures Julho 14, 2020 at 08:30 PM UTC